were treated with either omeprazole (40 mg every morning) and ciprofloxacin (500 mg twice daily) for one week (n=I1), omeprazole (40 mg every morning) and amoxicillin (500 mg four times daily) for one week (n=8), omeprazole (40 mg twice daily) and amoxicillin (500 mg four times daily) for one week (n= 12), omeprazole (20 mg twice daily) and amoxicillin (500 mg four times daily) for two weeks (n= 20), omeprazole (20 mg twice daily) day 1-14 and amoxicillin (500 mg four times daily) day [8] [9] [10] [11] [12] [13] [14] (n=9), omeprazole (20 mg twice daily) and amoxicillin (1 g twice daily) for two weeks (n= 15) or with omeprazole (2 x 20 mg twice daily) and roxithromycin (300 mg twice daily) for two weeks (n= 3). After the study period of treatment had ended, patients were treated with 300 mg ranitidine in the evening (n= 70) or 20 mg omeprazole (n=8) up to the six week follow up investigation. In patients with incomplete ulcer healing at that time (n= 18) treatment was continued with 20 mg omeprazole every morning until complete ulcer healing proved by endoscopy was achieved.
Patients routinely had an endoscopy before treatment and after six weeks. Patients with incomplete ulcer healing after six weeks were reinvestigated by endoscopy at four week intervals. During the follow up without any anti-ulcer treatment, patients were instructed to report to the study physicians with all symptoms related to their gastric ulcer disease, who suggested and performed repeat endoscopies. All endoscopically proved ulcer relapses were then registered. Beside these 'on demand' visits and endoscopies, was later identified as a gastric lymphoma and surgical resection was done. In a 40 year male patient with persistent H pyloni colonisation of the gastric mucosa, a chronic antral ulcer did not heal during the follow up of six months. We prospectively followed up 50 patients with healed ulcers for one year. H pylon infection was eradicated in 32 patients and persisted in 18 patients. These two groups of patients had similar demographic and clinical characteristics (Table II) . H pylon infection was a strong predictor of ulcer recurrences. Within the follow up period 10 of 18 post-treatment H pylori positive patients (55-6%) and only one of 32 patients with H pylon eradication (3 1%) had an endoscopically proved ulcer relapse (p<O0OOl, Table IV ). The ulcer recurrence after bacterial eradication was associated with diclofenac treatment. The H pylon reinfection rate in the first year after eradication was 6-25% (two of 32 patients). 
Discussion

